Association of CDKN2B-AS1 rs1333049 with Brain Diseases: A Case-control Study and a Meta-analysis
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: CDKN2B-AS1 polymorphisms were shown to associate with the risk of stroke in European. The goal of this study was to evaluate the contribution of CDKN2B-AS1 rs1333049 to the risk of hemorrhagic stroke (HS) and brain tumor (BT) in Han Chinese. Methods: A total of 142 HSs, 115 BTs, and 494 controls were included in the current association study. The genotyping test was performed using the melting temperature shift method. Results: We failed to validate the association of CDKN2B-AS1 rs1333049 with the risk of brain disease. Significantly higher levels of low-density lipoprotein cholesterol (LDL-C) (p=0.027), high-density lipoprotein cholesterol (HDL-C) (p<0.001) and total cholesterol (TC) (p<0.001) were found in HSs in the genotype GG/GC carriers, but not the genotype CC carriers (p>0.05). The meta-analysis of 10 studies among 133,993 individuals concluded that rs1333049 of CDKN2B-AS1 gene was likely to increase a 16% incidence rate of cerebrovascular disease (CD) among various populations (odds ratio 1.16, 95% confidence interval 1.08-1.25; p<0.0001, random-effect method). Conclusion: Our case-control study identified rs1333049 genotypes showed different association with the concentration of the LDL-C, HDL-C and TC in the HS patients. Meta-analysis supported the association between rs1333049 and CD risk in various populations, although we were unable to observe association between rs1333049 and the risk of HSs in Han Chinese.
Abstract
Objective: CDKN2B-AS1 polymorphisms were shown to associate with the risk of stroke in European. The goal of this study was to evaluate the contribution of CDKN2B-AS1 rs1333049 to the risk of hemorrhagic stroke (HS) and brain tumor (BT) in Han Chinese. Methods: A total of 142 HSs, 115 BTs, and 494 controls were included in the current association study. The genotyping test was performed using the melting temperature shift method. Results: We failed to validate the association of CDKN2B-AS1 rs1333049 with the risk of brain disease. Significantly higher levels of low-density lipoprotein cholesterol (LDL-C) (p=0.027), high-density lipoprotein cholesterol (HDL-C) (p<0.001) and total cholesterol (TC) (p<0.001) were found in HSs in the genotype GG/GC carriers, but not the genotype CC carriers (p>0.05). The meta-analysis of 10 studies among 133,993 individuals concluded that rs1333049 of CDKN2B-AS1 gene was likely to increase a 16% incidence rate of cerebrovascular disease (CD) among various populations (odds ratio 1.16, 95% confidence interval 1.08-1.25; p<0.0001, random-effect method). Conclusion: Our case-control study identified rs1333049 genotypes showed different association with the concentration of the LDL-C, HDL-C and TC in the HS patients. Meta-analysis supported the association between rs1333049 and CD risk in various populations, although we were unable to observe association between rs1333049 and the risk of HSs in Han Chinese.
참고문헌 (37)
- Labeyrie PE, "Neurological involvement in hereditary hemorrhagic telangiectasia", J Neuroradiol, 43, pp.236~245 (2016)
- Wei JW, "Current management of intracerebral haemorrhage in China: a national, multi-centre, hospital register study", BMC Neurol, 11, pp.16~ (2011)
- Sun Z, "Clinical diagnostic tools for screening of perioperative stroke in general surgery : a systematic review", Br J Anaesth, 116, pp.328~338 (2016)
- Ren C, "Assessment of serum UCH-L1 and GFAP in acute stroke patients", Sci Rep, 6, pp.24588~ (2016)
- Jarinova O, "Functional analysis of the chromosome 9p21.3coronary artery disease risk locus", Arterioscler Thromb Vasc Biol, 29, pp.1671~1677 (2009)
- Dehghan A, "Genome-wide association study for incident myocardial infarction and coronary heart disease in prospective cohort studies: the CHARGE consortium", PLoS One, 11, pp.e0144997~ (2016)
- Matsuoka R, "Association of six genetic variants with myocardial infarction", Int J Mol Med, 35, pp.1451~1459 (2015)
- Bayoglu B, "Polymorphisms in the long non-coding RNA CDKN2B-AS1 may contribute to higher systolic blood pressure levels in hypertensive patients", Clin Biochem, 49, pp.821~827 (2016)
- Bai Y, "Regulation of CARD8 expression by ANRIL and association of CARD8 single nucleotide polymorphism rs2043211(p.C10X) with ischemic stroke", Stroke, 45, pp.383~388 (2014)
- Huang Y, "Association of CDKN2BAS polymorphism rs4977574 with coronary heart disease : a case-control study and a metaanalysis", Int J Mol Sci, 15, pp.17478~17492 (2014)
- Kremer PH, "Evaluation of genetic risk loci for intracranial aneurysms in sporadic arteriovenous malformations of the brain", J Neurol Neurosurg Psychiatry, 86, pp.524~529 (2015)
- Adel Fahmideh M, "CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility", Carcinogenesis, 36, pp.876~882 (2015)
- Holdt LM, "Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks", PLoS Genet, 9, pp.e1003588~ (2013)
- Bochenek G, "The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10", Hum Mol Genet, 22, pp.4516~4527 (2013)
- Haslacher H, "9p21.3 risk locus is associated with first-ever myocardial infarction in an Austrian cohort", J Cardiovasc Med (Hagerstown), 17, pp.595~600 (2016)
- Cunnington MS, "Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL Expression", PLoS Genet, 6, pp.e1000899~ (2010)
- Dechamethakun S, "Associations between the CDKN2A", B, ADTRP and PDGFD polymorphisms and the development of coronary atherosclerosis in Japanese patients, 2014, pp.21, 680~690
- Hannou SA, "Functional genomics of the CDKN2A", B locus in cardiovascular and metabolic disease: what have we learned from GWASs?, 2015, pp.26, 176~184
- Popov N, "Epigenetic regulation of the INK4b-ARF-INK4a locus : in sickness and in health", Epigenetics, 5, pp.685~690 (2010)
- Karvanen J, "The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts", Genet Epidemiol, 33, pp.237~246 (2009)
- Smith JG, "Common genetic variants on chromosome 9p21 confers risk of ischemic stroke : a large-scale genetic association study", Circ Cardiovasc Genet, 2, pp.159~164 (2009)
- Dichgans M, "Shared genetic susceptibility to ischemic stroke and coronary artery disease : a genome-wide analysis of common variants", Stroke, 45, pp.24~36 (2014)
- Huang Y, "PPARD rs2016520 polymorphism and circulating lipid levels connect with brain diseases in Han Chinese and suggest sex-dependent effects", Biomed Pharmacother, 70, pp.7~11 (2015)
- Wang Z, "Sex-dichotomous effects of NOS1AP promoter DNA methylation on intracranial aneurysm and brain arteriovenous malformation", Neurosci Lett, 621, pp.47~53 (2016)
- Zhou S, "Association study of BUD13-ZNF259 gene rs964184 polymorphism and hemorrhagic stroke risk", Int J Clin Exp Med, 8, pp.22503~22508 (2015)
- Huang Y, "Relationship between chemokine(C-X-C motif)ligand 12gene variant(rs1746048)and coronary heart disease : case-control study and meta-analysis", Gene, 521, pp.38~44 (2013)
- Zhou J, "A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sex-dependent effect", Thromb Res, 130, pp.602~606 (2012)
- Sturiale CL, "Association between the rs1333040polymorphism on the chromosomal 9p21 locus and sporadic brain arteriovenous malformations", J Neurol Neurosurg Psychiatry, 84, pp.1059~1062 (2013)
- Sturiale CL, "Association between polymorphisms rs1333040 and rs7865618 of chromosome 9p21 and sporadic brain arteriovenous malformations", Cerebrovasc Dis, 37, pp.290~295 (2014)
- Bendjilali N, "Common variants on 9p21.3 are associated with brain arteriovenous malformations with accompanying arterial aneurysms", J Neurol Neurosurg Psychiatry, 85, pp.1280~1283 (2014)
- Nakaya N, "Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia : sub-analysis of the Japan Lipid Intervention Trial(J-LIT)", Circ J, 69, pp.1016~1021 (2005)
- Bharosay A, "Effect of lipid profile upon prognosis in ischemic and haemorrhagic cerebrovascular stroke", Indian J Clin Biochem, 29, pp.372~376 (2014)
- Waterworth DM, "Genetic variants influencing circulating lipid levels and risk of coronary artery disease", Arterioscler Thromb Vasc Biol, 30, pp.2264~2276 (2010)
- Ahmed W, "Association of ANRIL polymorphism(rs1333049 : C>G)with myocardial infarction and its pharmacogenomic role in hypercholesterolemia", Gene, 515, pp.416~420 (2013)
- Wibom C, "Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study", Cancer Epidemiol Biomarkers Prev, 24, pp.810~816 (2015)
- Chen SN, "The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis", BMC Cardiovasc Disord, 9, pp.3~ (2009)
- Hoppmann P, "No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drugeluting stents", JACC Cardiovasc Interv, 2, pp.1149~1155 (2009)
